Cyclosporine Treats Severe Poison Ivy in Case Study

Published Online: Wednesday, June 11, 2014
Follow Pharmacy_Times:
In a case study presented at the American Academy of Allergy Asthma and Immunology Annual Meeting, researchers successfully treated a 33-year-old patient with yearly, unavoidable poision ivy exposure without using steroids.

Instead, researchers used a 200-mg/day cyclosporine regimen during the patient's exposure period, which resulted in a resolution of poison ivy symptoms after 6 weeks of therapy. The dose was also decreased to 100 mg every other day without the poison ivy symptoms returning, and without the need for topical or systemic corticosteroids.

Related Articles
The FDA has received Akorn’s Paragraph IV filing seeking approval for its generic version of Allergan’s Restasis.
Allergic rhinitis can negatively impact one’s quality of life by impairing concentration and causing fatigue and sleep disturbances.
Latest Issues
$auto_registration$